Bastiaan Maes
- Work address
-
C. Heymanslaan 10, ingang 12 - verdieping 6
9000 Gent - Bastiaan.Maes@UGent.be
Show
Sort by
-
TAOK3 regulates type 2 immune responses in the lung and adipose tissue
(2023) -
- Miscellaneous
- open access
A Complement Atlas identifies interleukin 6 dependent alternative pathway dysregulation as a key druggable feature of COVID-19
-
- Journal Article
- A1
- open access
Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
-
- Journal Article
- A1
- open access
Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19 : an open-label randomized controlled trial
-
The STE20 kinase TAOK3 controls the development of house dust mite-induced asthma in mice
-
- Journal Article
- A1
- open access
TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C
-
Effect of anti-interleukin drugs in patients with COVID-19 and signs of cytokine release syndrome (COV-AID) : a factorial, randomised, controlled trial
-
- Journal Article
- A1
- open access
A20 deficiency in myeloid cells protects mice from diet-induced obesity and insulin resistance due to increased fatty acid metabolism
-
- Journal Article
- A1
- open access
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19 : a meta-analysis
-
Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC) : a structured summary of a study protocol for a randomised controlled trial (vol 21, 491, 2020)